Quarterly Activities Update: Encouraging Growth for geneType Commercial Test Volume

MELBOURNE, Australia, July 28, 2023 -- Genetic Technologies Limited , a global leader in guideline-driven genomics-based testing in health, wellness and serious diseases, is pleased to provide this...

Related Keywords

Melbourne ,Victoria ,Australia ,United States ,Boston ,Massachusetts ,Chicago ,Illinois ,American ,Adrian Mulcahy ,Erika Spaeth ,Simon Morriss ,Genetic Technologies Limited ,Clinical Medical Affairs ,A National Television ,Board Of Genetic Technologies ,Biotechnology Innovation Organisation ,American Society Of Clinical Oncologists ,Genetic Technologies ,Exchange Commission ,Nasdaq ,Technologies Limited ,Quarterly Business Update ,Type Multi Risk ,National Television ,American Society ,Clinical Oncologists ,Chief Executive Officer Simon Morriss ,Medical Science Liaison ,Achievements During ,Type Breast Cancer Risk Assessment Test ,Studies Validating Genetype ,Prostate Cancers Risk ,Pancreatic Cancer Risk Assessment ,Executive Officer ,Prostate Cancer ,United Kingdom Biobank ,Type Prostate Cancer Risk Assessment Test ,Polygenic Risk Score ,Medical Affairs ,Markets ,